Eli Lilly

Eli Lilly

company United States

Eli Lilly and Company is an American pharmaceutical company, founded in 1876, that is known for its contributions to the development of various medications across multiple therapeutic areas, including diabetes, oncology, and immunology. The company has gained recognition for its diabetes treatment, Mounjaro, which is part of the GLP-1 receptor agonist class. Eli Lilly is committed to improving patient outcomes through innovative products and has a strong focus on research and development.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
3,619
Power
97$
Sentiment
5.50
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Slovenia 2 5.50 0.17% +0% 2,078,938 3,619 $56,000 97$
Totals 2 2,078,938 3,619 $56,000 97$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Slovenia Slovenia: American Eli Lilly has significantly impacted the market with its own weight loss drugs. 6

Delo – major Slovenian daily, est. 1959: Prelomnica za farmacevtskega velikana Novo Nordisk

Slovenia Slovenia: Eli Lilly is a pharmaceutical giant that announced the results of a clinical study for its obesity pill, orforglipron. 5

Delo – major Slovenian daily, est. 1959: Na trg vstopa tableta za hujšanje, ki naj bi postala vodilna na trgu

Denmark Denmark: Eli Lilly is mentioned as a competitor to Novo Nordisk in the context of weight loss medication. 5

Politiken: Novo-kollaps kostede milliarder i danskernes pensionsopsparing

Estonia Estonia: Eli Lilly is a competitor that has introduced better products in the weight loss market. 7

Postimees – major Estonian daily, est. 1857: Kaalulangetus­kuningas on langenud

Germany Germany: Eli Lilly is a US pharmaceutical company involved in the pricing controversy of the drug Mounjaro. 3

Süddeutsche Zeitung: Eli Lilly: Geheimpreis für Mounjaro - Gesundheit